Literature DB >> 23052600

Amyotrophic lateral sclerosis in Sardinia, insular Italy, 1995-2009.

Maura Pugliatti1, Leslie D Parish, Paola Cossu, Stefania Leoni, Anna Ticca, M Valeria Saddi, Enzo Ortu, Sebastiano Traccis, Giuseppe Borghero, Roberta Puddu, Adriano Chiò, Pietro Pirina.   

Abstract

Recent genetic studies suggest a Sardinian type of amyotrophic lateral sclerosis (ALS). Thus, ALS incidence, prevalence and survival were investigated in a large population of Sardinians aimed to disclose population-specific patterns and their temporal changes. This is a population-based incidence and prevalence study in northern and central Sardinia, insular Italy (over 700,000 population). Incidence rates were computed for the time interval 1995-2009 and by quinquennia. Prevalence was computed for prevalence days 31 December 2004 and 2009. Onset-based survival for 1995-2009 is also reported. All ALS patients (El Escorial Criteria) in the study area were retrospectively included. The ALS crude incidence from 2005-2009 was 2.5 (95 % CIs: 0.1, 4.9), 3.4 in men and 1.6 in women. Onset occurred most often between the age of 65-74 years in men and 55-64 years in women. The ALS incidence tended to increase over the period 1995-2009. The mean age at onset was 61.7 years with no difference based on gender, varying significantly from 59.9 years in 1995-1999 to 63.9 years in 2005-2009. On December 31, 2009, the ALS crude prevalence was 10.8 per 100,000 (95 % CIs: 8.6, 13.1), 13.8 in men and 8.0 in women, whereas it was 6.3 per 100,000 (95 % CIs: 4.1, 8.6) on December 31, 2004 (M:F ratio of 0.95). Mean survival from onset was 37.0 months, with no difference based on gender, and a tendency to decrease during the period 1995-2009, in relation to type and age of onset. The population-based incidence and prevalence data of ALS in Sardinians indicate an increase of the disease occurrence over the past 40 years, providing support for a population-specific variant of ALS in Sardinia.

Entities:  

Mesh:

Year:  2012        PMID: 23052600     DOI: 10.1007/s00415-012-6681-5

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  41 in total

1.  Genetic factors and the founder effect explain familial MS in Sardinia.

Authors:  M G Marrosu; M Lai; E Cocco; V Loi; G Spinicci; M P Pischedda; S Massole; G Marrosu; P Contu
Journal:  Neurology       Date:  2002-01-22       Impact factor: 9.910

2.  The epidemiology of motor neurone disease in two counties in the southwest of England.

Authors:  Ibrahim Imam; Susan Ball; Dave Wright; C Oliver Hanemann; John Zajicek
Journal:  J Neurol       Date:  2010-01-22       Impact factor: 4.849

3.  Large proportion of amyotrophic lateral sclerosis cases in Sardinia due to a single founder mutation of the TARDBP gene.

Authors:  Adriano Chiò; Giuseppe Borghero; Maura Pugliatti; Anna Ticca; Andrea Calvo; Cristina Moglia; Roberto Mutani; Maura Brunetti; Irene Ossola; Maria Giovanna Marrosu; Maria Rita Murru; Gianluca Floris; Antonino Cannas; Leslie D Parish; Paola Cossu; Yevgeniya Abramzon; Janel O Johnson; Michael A Nalls; Sampath Arepalli; Sean Chong; Dena G Hernandez; Bryan J Traynor; Gabriella Restagno
Journal:  Arch Neurol       Date:  2011-01-10

4.  Epidemiologic study of amyotrophic lateral sclerosis in Sardinia, Italy.

Authors:  M Giagheddu; G Puggioni; C Masala; F Biancu; G Pirari; M R Piras; M G Rachele
Journal:  Acta Neurol Scand       Date:  1983-12       Impact factor: 3.209

5.  Pseudopolyneuritic form of ALS revisited: clinical and pathological heterogeneity.

Authors:  Zen Kobayashi; Kuniaki Tsuchiya; Tetsuaki Arai; Osamu Yokota; Sadakiyo Watabiki; Hideki Ishizu; Haruhiko Akiyama; Hidehiro Mizusawa
Journal:  Neuropathology       Date:  2009-12-28       Impact factor: 1.906

6.  Amyotrophic lateral sclerosis in Sardinia, Italy: an epidemiologic study.

Authors:  M Giagheddu; V Mascia; A Cannas; M I Pirastru; F Sanna; M G Rachele; A Brundu; B Murgia
Journal:  Acta Neurol Scand       Date:  1993-06       Impact factor: 3.209

Review 7.  Motor neuron disease in the Province of Turin, Italy, 1971-1980.

Authors:  M Leone; A Chio; P Mortara; M G Rosso; D Schiffer
Journal:  Acta Neurol Scand       Date:  1983-11       Impact factor: 3.209

8.  Studies on epidemiological, clinical, and etiological aspects of ALS disease in Sardinia, Southern Italy.

Authors:  G Rosati; L Pinna; E Granieri; I Aiello; R Tola; V Agnetti; A Pirisi; P de Bastiani
Journal:  Acta Neurol Scand       Date:  1977-03       Impact factor: 3.209

9.  The C9ORF72 expansion mutation is a common cause of ALS+/-FTD in Europe and has a single founder.

Authors:  Bradley N Smith; Stephen Newhouse; Aleksey Shatunov; Caroline Vance; Simon Topp; Lauren Johnson; Jack Miller; Younbok Lee; Claire Troakes; Kirsten M Scott; Ashley Jones; Ian Gray; Jamie Wright; Tibor Hortobágyi; Safa Al-Sarraj; Boris Rogelj; John Powell; Michelle Lupton; Simon Lovestone; Peter C Sapp; Markus Weber; Peter J Nestor; Helenius J Schelhaas; Anneloor Alm Ten Asbroek; Vincenzo Silani; Cinzia Gellera; Franco Taroni; Nicola Ticozzi; Leonard Van den Berg; Jan Veldink; Phillip Van Damme; Wim Robberecht; Pamela J Shaw; Janine Kirby; Hardev Pall; Karen E Morrison; Alex Morris; Jacqueline de Belleroche; J M B Vianney de Jong; Frank Baas; Peter M Andersen; John Landers; Robert H Brown; Michael E Weale; Ammar Al-Chalabi; Christopher E Shaw
Journal:  Eur J Hum Genet       Date:  2012-06-13       Impact factor: 4.246

10.  Molecular characterization of wilson disease in the Sardinian population--evidence of a founder effect.

Authors:  G Loudianos; V Dessi; M Lovicu; A Angius; A Figus; F Lilliu; S De Virgiliis; A M Nurchi; A Deplano; P Moi; M Pirastu; A Cao
Journal:  Hum Mutat       Date:  1999       Impact factor: 4.878

View more
  13 in total

Review 1.  Clinical and demographic factors and outcome of amyotrophic lateral sclerosis in relation to population ancestral origin.

Authors:  Benoît Marin; Giancarlo Logroscino; Farid Boumédiene; Anaïs Labrunie; Philippe Couratier; Marie-Claude Babron; Anne Louise Leutenegger; Pierre Marie Preux; Ettore Beghi
Journal:  Eur J Epidemiol       Date:  2015-10-12       Impact factor: 8.082

Review 2.  The epidemiology of ALS: a conspiracy of genes, environment and time.

Authors:  Ammar Al-Chalabi; Orla Hardiman
Journal:  Nat Rev Neurol       Date:  2013-10-15       Impact factor: 42.937

3.  Factors predicting survival in ALS: a multicenter Italian study.

Authors:  Andrea Calvo; Cristina Moglia; Christian Lunetta; Kalliopi Marinou; Nicola Ticozzi; Gianluca Drago Ferrante; Carlo Scialo; Gianni Sorarù; Francesca Trojsi; Amelia Conte; Yuri M Falzone; Rosanna Tortelli; Massimo Russo; Adriano Chiò; Valeria Ada Sansone; Gabriele Mora; Vincenzo Silani; Paolo Volanti; Claudia Caponnetto; Giorgia Querin; Maria Rosaria Monsurrò; Mario Sabatelli; Nilo Riva; Giancarlo Logroscino; Sonia Messina; Nicola Fini; Jessica Mandrioli
Journal:  J Neurol       Date:  2016-10-24       Impact factor: 4.849

4.  Stratification of ALS patients' survival: a population-based study.

Authors:  Benoît Marin; Philippe Couratier; Simona Arcuti; Massimiliano Copetti; Andrea Fontana; Marie Nicol; Marie Raymondeau; Giancarlo Logroscino; Pierre Marie Preux
Journal:  J Neurol       Date:  2015-10-30       Impact factor: 4.849

5.  Genetic architecture of ALS in Sardinia.

Authors:  Giuseppe Borghero; Maura Pugliatti; Francesco Marrosu; Maria Giovanna Marrosu; Maria Rita Murru; Gianluca Floris; Antonino Cannas; Leslie D Parish; Patrizia Occhineri; Tea B Cau; Daniela Loi; Anna Ticca; Sebastiano Traccis; Umberto Manera; Antonio Canosa; Cristina Moglia; Andrea Calvo; Marco Barberis; Maura Brunetti; Hannah A Pliner; Alan E Renton; Mike A Nalls; Bryan J Traynor; Gabriella Restagno; Adriano Chiò
Journal:  Neurobiol Aging       Date:  2014-07-18       Impact factor: 4.673

6.  Black hairy tongue in a patient with amyotrophic lateral sclerosis.

Authors:  Matteo Erriu; Francesca Maria Giovanna Pili; Gloria Denotti; Valentino Garau
Journal:  J Int Soc Prev Community Dent       Date:  2016 Jan-Feb

7.  Age-specific ALS incidence: a dose-response meta-analysis.

Authors:  Benoît Marin; Andrea Fontana; Simona Arcuti; Massimilano Copetti; Farid Boumédiene; Philippe Couratier; Ettore Beghi; Pierre Marie Preux; Giancarlo Logroscino
Journal:  Eur J Epidemiol       Date:  2018-04-23       Impact factor: 8.082

Review 8.  Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature.

Authors:  A Chiò; G Logroscino; B J Traynor; J Collins; J C Simeone; L A Goldstein; L A White
Journal:  Neuroepidemiology       Date:  2013-07-11       Impact factor: 3.282

Review 9.  A fruitful endeavor: modeling ALS in the fruit fly.

Authors:  Ian Casci; Udai Bhan Pandey
Journal:  Brain Res       Date:  2014-10-05       Impact factor: 3.252

10.  Neuropathological profile of long-duration amyotrophic lateral sclerosis in military Veterans.

Authors:  Keith R Spencer; Zachariah W Foster; Nazifa Abdul Rauf; Latease Guilderson; Derek Collins; James G Averill; Sean E Walker; Ian Robey; Jonathan D Cherry; Victor E Alvarez; Bertrand R Huber; Ann C McKee; Neil W Kowall; Christopher B Brady; Thor D Stein
Journal:  Brain Pathol       Date:  2020-08-04       Impact factor: 6.508

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.